TRxADE (MEDS) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 11/18/22
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial ResultsGlobeNewsWire • 11/07/22
TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m.Accesswire • 10/24/22
TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr.GlobeNewsWire • 10/03/22
Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services DealAccesswire • 09/20/22
TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus ProgramGlobeNewsWire • 08/30/22
TRxADE HEALTH, Inc.'s (MEDS) CEO Suren Ajjarapu on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/26/22
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial ResultsAccesswire • 07/25/22
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLCAccesswire • 07/12/22
TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m.Accesswire • 07/11/22
Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine ServicesAccesswire • 05/19/22
TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial ResultsAccesswire • 05/09/22